PhagePro is an early-stage biotechnology therapeutics company that develops bacteriophage-based products to help the world’s most vulnerable communities.
NEW—An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections, more deaths than HIV/AIDS or malaria.
#GRAMPaper reveals the scale of antimicrobial resistance (#AMR), now a leading cause of death worldwide: https://t.co/2h5UEKemEq #AMRSOS
What next on infections and deaths caused by #AMR in Kenya? Find out more on the steps of #phage regulation #frameworks that was recently organized by @KEMRI_Kenya@PhagesforGH
https://t.co/iRHohNrG11
.@NatGeo visited and wrote about Dr. Lillian Musila (@KEMRI_Kenya) and her colleagues about their identification of over 150 #phages and work toward using them to address #AMR. The article features several Phages for Global Health researchers!
https://t.co/OGVTmLNueJ
Here is something dear to our heart at IBRT
A documentary of the audacity of a group of undergraduates in Africa exploring the fields of #bacteriophage biology, #Bioinformatics, #CancerResearch, #AMR
Introducing Phamilia 2.0, a journal by Ibadan Bacteriophage Research Team.
Congratulations to @PhagePro for being awarded the 2022 Eddie in the MINORITY OWNED Track! We're so proud to have you as a member of this year's cohort and are excited to see what this next chapter of #innovation holds for you all!
People often tell us that #cholera is an ancient disease. It is not. It is a disease that impacts millions of people every day. We need more resources and more solutions. Thank you to the @nytimes for bringing more attention to this pandemic.
https://t.co/usAoeRPoWe
https://t.co/NAE5rAZdNl
I am thrilled to share that I’ve been admitted to a summer internship with @electiveafrica Africa, where I will have the opportunity to shadow doctors in a field hospital in Mombasa, Kenya.
A huge welcome to our new intern Naya Pabla! Thank you for choosing to spend your summer with us. We can't wait to learn and grow together over the next 6 weeks!
#PhageTherapy#Intern#WomenInScience#STEMCareers
Thank you to Emily Leclerc at https://t.co/mM6rnGlWXB for including our CEO Dr. Minmin Yen in this article on phage therapy! Please give it a read to learn more about the work the community is doing to push forward phage therapy in the clinic.
https://t.co/Ech1LNrTX7
@MIT_alumni ICYMI: Our CEO Dr. Yen was a featured MIT alumna this past May for her 10-year reunion. Read the article to find out more about our work here at PhagePro and our mission to be more inclusive in global health and biotech!
Alum cofounded @PhagePro is in the early stages of using bacteriophages—viruses that target and kill specific bacteria—to fight cholera in the developing world. https://t.co/gUCDN0e7xX